Top News
Hinge Health is reportedly considering postponing its much-anticipated IPO due to stock market volatility.
The company filed IPO plans last month. Its most recent funding round in October 2021 valued the company at $6…
Several months have passed without a digital health IPO, but that’s about to change with virtual physical therapy business Hinge Health’s move to file an S-1 last month. MedCity News Editor-in-Chief Arundhati Parmar and…
Continue Reading
Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round.The round included new primary investors KIRKBI, M&G Investments and Lightrock, with participation from existing shareholders….
Continue Reading
Hinge Health, a digital musculoskeletal care platform, filed for an IPO on Monday with the U.S. Securities and Exchange Commission to go public under the symbol HNGE, despite recent stock market volatility due to uncertainty…
Continue Reading
PAVmed, a medical technology company focused on devices, diagnostics and digital health, and its subsidiary, cancer care platform Veris Health, completed a $2.37 million private placement financing.Accredited investors acquired PAVmed securities priced at-the-market and…
Continue Reading
The U.S. stock market, especially the tech-heavy NASDAQ, was deeply (no pun intended) rattled by a Chinese AI upstart called DeepSeek on Monday. It appears to have accomplished much of what large language models…
Continue Reading
DarioHealth, a digital chronic condition management platform, closed a $25.6 million private placement of convertible preferred stock, with most of the funds secured from existing shareholders. The balance of the funds was provided by a…
Continue Reading
Top News
Walgreens announces Q1 results: revenue up 7.5%, EPS –$0.31 versus –$0.08, beating expectations for both. Shares of WBA, the worst-performing stock in the S&P 500 last year, jumped 27% Friday on the news….
Continue Reading
A notable marriage is occurring in the world of digital health: Transcarent has claimed Accolade for $621 million. But by no means is this a marriage of equals given how the latter is being…
Continue Reading
What You Should Know:
– Transcarent, a health and care platform, announced today that it will acquire Accolade (NASDAQ: ACCD), a leader in health advocacy and primary care, for $7.03 per share in cash, representing…
Continue Reading
